4/15/2013 | CAHYLM | Angiotech calls all 9% floaters due 2013, 9% senior notes due 2016
|
4/2/2013 | CAHY | Angiotech Pharmaceuticals ends 2012 with improved cash flow, $69 million liquidity, lower debt ratio
|
3/25/2013 | BK | Angiotech to repay loans, buy back floaters and notes via asset sale
|
3/25/2013 | CAHYLM | Angiotech to repay loans, buy back floaters and notes via asset sale
|
3/18/2013 | CAHYLM | Angiotech to redeem $16 million of senior secured floaters due 2013
|
9/18/2012 | CAHYLM | Angiotech plans to redeem $40 million, $22,000 of floaters due 2013
|
8/10/2012 | CAHYLM | Angiotech wraps oversubscribed offer to exchange $225 million floaters
|
7/27/2012 | CAHYLM | Angiotech extends floating-rate notes exchange offer, increases cap
|
7/3/2012 | CAHYLM | Angiotech begins exchange offer for up to $200 million of floaters
|
4/10/2012 | CAHY | Angiotech slashed debt load, leverage, confident about 2013 notes refi
|
3/16/2012 | BKCAHYLM | Angiotech loosens loan terms, may now buy back floating-rate notes
|
8/11/2011 | CAHY | Angiotech reorganizes for solid quarter; starts balance sheet anew
|
8/9/2011 | DD | Angiotech's U.S. Chapter 15 and Canadian CCAA cases are closed
|
7/15/2011 | DD | Angiotech asks court to close Chapter 15 case; CCAA plan implemented
|
5/12/2011 | CADDHYLM | Angiotech executes plan of arrangement, exchanges 73/4% notes, floaters
|
4/29/2011 | CADDHYLM | Angiotech further extends exchange offer for floating-rate notes
|
4/25/2011 | CADDHYLM | Angiotech recapitalization, exchange offer deadlines extended
|
4/7/2011 | DD | Angiotech CCAA plan sanctioned by B.C. court; order recognized in U.S.
|
4/5/2011 | DD | Angiotech: 100% of creditors approve amended reorganization plan
|
4/1/2011 | DD | Angiotech amends CCAA plan, shifting allotment of some shares
|
3/30/2011 | DDHYLM | Angiotech again extends exchange offer for floating-rate notes
|
3/18/2011 | DD | Angiotech eyes U.S. court approval of settlement sanctioned in Canada
|
3/4/2011 | DDHYLM | Angiotech extends floating-rate notes exchange offer to March 30
|
2/24/2011 | CADDHY | Angiotech, noteholders agree to amend exchange offer support agreement
|
2/18/2011 | DD | Angiotech unit, Rex agree to terminate license and marketing deal
|
2/10/2011 | DD | Angiotech Pharmaceuticals secures $28 million revolving DIP facility
|
2/9/2011 | CADDHYLM | Angiotech noteholders extend exchange offer launch deadline to Feb. 10
|
1/31/2011 | DD | Angiotech files Chapter 15 bankruptcy, seeks recognition of CCAA case
|
1/28/2011 | BKCADDHY | Moody's cuts Angiotech
|
1/28/2011 | CADDHY | Angiotech to complete recapitalization via Canadian CCAA proceeding
|
1/26/2011 | CADDHY | Angiotech license agreement terminated by Rex amid breach allegations
|
1/12/2011 | CADDHY | Angiotech noteholders agree to extend exchange offer deadlines
|
12/22/2010 | CADDHY | Angiotech 73/4% subordinated notes payment grace period extended
|
12/17/2010 | DDHY | Angiotech noteholders agree to extend exchange offer launch deadlines
|
12/2/2010 | DDHY | Angiotech exchange offer deadlines extended; Rex granted injunction
|
11/24/2010 | DD | Angiotech license agreement party files wrongful termination suit
|
11/12/2010 | CA | Market Commentary: Primary expected to pick up; Cogeco firms 12 bps in trading; Canada junk bonds rally
|
11/12/2010 | DD | Market Commentary: Distressed market 'kind of heavy'; market tone pressures NewPage; Angiotech bonds creeping up
|
11/12/2010 | HY | Distressed market 'kind of heavy'; market tone pressures NewPage; Angiotech creeping up
|
11/9/2010 | BKCADDHY | Angiotech default forbearance, Wells Fargo credit agreement amended
|
11/2/2010 | BKDDHY | Moody's lowers Angiotech
|
10/29/2010 | BKCADDHY | Angiotech agrees with 73% of noteholders to exchange debt for stock
|
10/8/2010 | BKCVDDEMHY | Prospect News records three new defaults for week; S&P marks two
|
10/6/2010 | DD | Angiotech stockholder representative makes demand, files lawsuit concerning merger
|
10/4/2010 | BKDDHY | S&P cuts Angiotech
|
10/1/2010 | BKCADDHY | Angiotech skips subordinated notes payment amid noteholder talks
|
8/10/2010 | BKDDHY | S&P drops Angiotech
|
11/9/2009 | BKBWHY | Angiotech focused on reinvesting cash to grow business
|
11/9/2009 | BKDDHYSS | Angiotech needs more liquidity to ensure survival beyond 2010
|
10/7/2009 | BKDDHY | S&P upgrades Angiotech
|
7/23/2009 | CVHY | Angiotech Pharmaceuticals files $250 million shelf registration
|
6/25/2009 | BKDDHY | S&P may upgrade Angiotech
|
6/3/2009 | BK | Angiotech gains access to entire revolver, removes delayed-draw loan
|
3/5/2009 | BKBWHY | Angiotech says new Wells Fargo credit facility addresses near-term liquidity needs
|
3/2/2009 | BK | Angiotech gets new $32.5 million credit facility
|
2/4/2009 | HY | Market Commentary: El Paso, Landry's bring deals at discount; NOVA jumps on funding deal report; gaming names clobbered again
|
1/30/2009 | SS | Interinvest reports 6.22% stake in Angiotech
|
12/31/2008 | BKHY | S&P affirms Angiotech
|
12/18/2008 | SS | Angiotech Pharmaceuticals shareholder cuts stake to 8.8%
|
12/17/2008 | BKDDHY | S&P affirms Angiotech
|
9/25/2008 | SS | Investor sees greater value in Angiotech Pharmaceuticals, suggests recapitalization, possible sale
|
9/23/2008 | BKDDHY | S&P keeps Angiotech on watch
|
9/23/2008 | BKDDHY | Moody's drops Angiotech
|
9/23/2008 | HY | Angiotech cancels tender for $165 million of floaters, 73/4% notes
|
9/12/2008 | HY | Angiotech again prolongs tender deadline for $165 million of floaters, 73/4% notes
|
8/22/2008 | HY | Angiotech delays tender deadline for $165 million of floaters, 73/4% notes
|
7/8/2008 | BKDDHY | S&P lowers Angiotech
|
7/7/2008 | HY | Angiotech tenders for $165 million of floaters, 73/4% notes
|
7/2/2008 | BKHY | Moody's may lower Angiotech
|
4/3/2008 | HY | Market Commentary: Bombardier, Finlay bonds rise on earnings; Thornburg rally fizzles out; funds see $373 million inflow
|
3/26/2008 | DD | Market Commentary: Thornburg rally marches on; Linens better, Pep Boys down; AbitibiBowater bonds still gaining
|
10/24/2007 | BKHY | Moody's lowers Angiotech
|
10/22/2007 | BKHY | S&P: Angiotech on watch
|
10/19/2007 | HY | Market Commentary: US Investigations prices; Angiotech slides on earnings warning; Trump, GMAC ease in active dealings
|
8/7/2007 | BKHY | S&P lowers Angiotech
|
3/23/2007 | BKHY | S&P lowers Angiotech outlook to negative
|
3/13/2007 | BKHY | Moody's downgrades Angiotech
|
11/30/2006 | BKHY | Moody's cuts Angiotech, rates note Ba3
|
11/30/2006 | HY | New Issue: Angiotech $325 million seven-year notes yield Libor plus 375 bps
|
11/30/2006 | HY | Market Commentary: VWR, United Auto price; GM bonds up on GMAC deal closing; funds see $249 million outflow
|
11/29/2006 | HY | Angiotech talks $325 million seven-year notes at Libor plus 325-350 bps
|
11/29/2006 | HY | Market Commentary: Momentive, Complete Production price; Revlon up on financing, Houghton Mifflin on M&A
|
11/28/2006 | HY | Market Commentary: Airline slide continues, market mulls Harrah's buzz; Chesapeake, OPTI Canada slate deals
|
11/27/2006 | SS | Ford shares, preferreds skid; Nasdaq, LSE slip; biotechs lower; Raytheon drops; Ventas falls
|
11/27/2006 | HY | Angiotech offers $325 million seven-year floating-rate notes via Credit Suisse, Banc of America Securities
|
11/27/2006 | HY | Market Commentary: Ford weathers triple ratings hit; Six flags off; Regency Energy slates deal; funds see $25 million outflow
|
11/27/2006 | BK | Angiotech to repay term loan with note proceeds
|
11/10/2006 | BT | Angiotech still at neutral by Merrill
|
11/10/2006 | BT | RBC maintains Angiotech at outperform
|
11/2/2006 | BT | RBC has Angiotech at outperform
|
11/1/2006 | BT | Market Commentary: Alexion stock climbs following earnings; Angiotech stock gives up almost 6% on 3Q earnings
|
11/1/2006 | BT | Angiotech: royalties of $43.7 million boost third-quarter revenues to $86.3 million
|
11/1/2006 | BT | Angiotech maintains Merrill's neutral rating
|
10/24/2006 | BT | Angiotech at neutral by Merrill
|
10/19/2006 | BT | Merrill rates Angiotech neutral
|
10/3/2006 | BT | Angiotech cut to neutral by Merrill
|
9/28/2006 | BKDDHY | Moody's introduces new ratings
|
9/22/2006 | BT | Angiotech kept at buy by Merrill
|
9/22/2006 | BT | RBC rates Angiotech at outperform
|
9/18/2006 | BT | Angiotech: Data show Vascular Wrap cuts neointimal hyperplasia by 87.6%
|
9/6/2006 | BT | Angiotech at buy by Merrill
|
8/30/2006 | BT | Merrill rates Angiotech at buy
|
8/24/2006 | BT | Angiotech to sell Contour Threads reconstructive surgical products in Europe
|
8/17/2006 | BT | Angiotech begins enrollment in hemodialysis safety trial
|
8/4/2006 | BT | Angiotech rated at outperform by RBC
|
8/4/2006 | BT | Merrill has Angiotech at buy
|
8/3/2006 | BT | Merrill keeps Angiotech at buy
|
7/27/2006 | BT | Angiotech given buy rating by Merrill
|
6/22/2006 | BT | Angiotech at buy by Merrill
|
5/26/2006 | BT | Angiotech at buy by Merrill
|
5/26/2006 | BT | RBC gives Angiotech outperform rating
|
5/25/2006 | BT | Angiotech to acquire Quill Medical for $40 million
|
5/25/2006 | BT | Market Commentary: Cubist explodes ahead of Cubicin vote; Encysive advances; Seattle Genetics, Progenics gain on pact
|
5/10/2006 | BT | Angiotech at buy by Merrill
|
5/9/2006 | BT | Angiotech, Genzyme to develop surgical oncology treatments
|
5/4/2006 | BT | Merrill maintains Angiotech at buy
|
4/25/2006 | BT | Merrill keeps Angiotech at buy
|
4/7/2006 | BT | Angiotech: Data shows Adhibit reduces surgical adhesions in patients after myomectomy
|
3/23/2006 | BK | Market Commentary: LSP Gen, Quintiles, Panavision, Aveta tweak deals; Dole sets talk; Cablevision, Angiotech break
|
3/21/2006 | BT | Orthovita, Angiotech enter into license agreement for Vitagel surgical hemostat
|
3/17/2006 | BK | Market Commentary: HealthSouth, Select Medical gain ground on reimbursement chatter; Angiotech upsizes, cuts spread
|
3/17/2006 | HY | Market Commentary: GM loss restatement, reporting delay tows autos lower; SBA gains
|
3/16/2006 | HY | Market Commentary: Angiotech deal prices; Young up on KRON joining network; funds see $404 million outflow
|
3/16/2006 | BTHY | New Issue: Angiotech sells $250 million eight-year notes to yield 73/4%
|
3/14/2006 | BT | Angiotech, Boston Scientific's registry results confirm safety of Taxus stent
|
3/13/2006 | BT | Merrill rates Angiotech at buy
|
3/13/2006 | HY | Market Commentary: Quicksilver prices upsized deal; Aztar bonds up on merger news
|
3/13/2006 | BTHY | Angiotech Pharmaceuticals talks $250 million eight-year notes at 73/4%-8%
|
3/10/2006 | HY | Market Commentary: Levi Strauss two-part deal prices; Dana keeps heading north
|
3/8/2006 | BT | Angiotech partner submits final module for Taxus Liberte coronary stent system application
|
3/3/2006 | BKBTHY | S&P assigns Angiotech Pharmaceuticals, loan BB-, notes B
|
3/3/2006 | BT | Market Commentary: Angiotech to sell bonds, bank debt; Advanced Magnetics rises; Celgene on tear of new highs
|
3/3/2006 | HY | Market Commentary: Dave & Buster's prices eight-year deal; AK up on takeover buzz; bankrupt Dana climbs
|
3/3/2006 | BTHY | Angiotech Pharmaceuticals to start roadshow for $250 million eight-year notes Tuesday
|
3/2/2006 | BT | Merrill rates Angiotech at buy
|
3/2/2006 | BK | Market Commentary: John Maneely, Angiotech, Caribe, Captain D's set talk; Easton-Bell seen at tight end; Sunny D trades up
|
3/2/2006 | BKBTHY | Moody's rates Angiotech Pharmaceutical loan Ba3, notes B2
|
2/28/2006 | BKBT | Angiotech sets Thursday launch for $375 million credit facility
|
2/24/2006 | BT | Conor Medsystems wins U.K. patent suit, Angiotech plans an appeal
|
2/24/2006 | BT | Merrill puts Angiotech at buy
|
2/7/2006 | BT | Merrill rates Angiotech at buy
|
2/6/2006 | BT | Merrill ups Angiotech to buy
|
2/2/2006 | BT | Merrill maintains Angiotech at neutral
|
2/1/2006 | BT | Angiotech rated at neutral by Merrill
|
2/1/2006 | BT | Market Commentary: Vertex gains; SGX debuts higher; Angiotech up; Alnylam off; DUSA dives; Endo slides; Isis bounces
|
2/1/2006 | BKBTHY | Angiotech plans $375 million credit facility, $300 million bonds for American Medical purchase
|
2/1/2006 | BT | Angiotech to acquire American Medical Instruments for $785 million
|
1/31/2006 | BT | Merrill stays neutral on Angiotech
|
1/9/2006 | BT | Merrill maintains Angiotech at neutral
|
1/5/2006 | BT | Angiotech launches study of catheters coated with non-antibiotic anti-infective
|
12/20/2005 | BT | Angiotech: FDA labels Vascular Wrap paclitaxel-eluting graft a 'device,' paving way for faster approval
|
11/17/2005 | BT | Angiotech reports Vascular Wrap safe in patients with peripheral vascular disease
|
11/9/2005 | BT | Market Commentary: CombinatoRx surges on debut; Angiotech off; Fisher issues soar; Digene slips on stock sale plans
|
11/4/2005 | BT | Merrill Lynch keeps Angiotech at neutral
|
11/3/2005 | BT | Angiotech to acquire vascular graft product line from Edwards Lifesciences for $14 million
|
10/31/2005 | BT | Merrill Lynch maintains Angiotech neutral rating
|
10/25/2005 | BT | Independent Stent registry shows Taxus Stent to be effective
|
10/19/2005 | BT | Boston Scientific says Angiotech's Taxus stent is safe and effective
|
10/14/2005 | BT | Angiotech retains neutral rating from Merrill
|
9/27/2005 | BT | Angiotech cut by Merrill to neutral
|
9/13/2005 | BT | Angiotech to acquire Afmedica
|
9/13/2005 | BT | Market Commentary: Immunomedics up; OSI rebounds; Celgene retreats; Protein Design Labs, Novavax, Cephalon all up
|
8/5/2005 | BT | Angiotech maintained by Merrill at buy
|
7/20/2005 | BT | Angiotech upgraded Jennings to hold
|